Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) traded up 17.4% during trading on Wednesday . The company traded as high as $1.35 and last traded at $1.35. 205 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 7,506 shares. The stock had previously closed at $1.15.
Nutriband Trading Up 33.3 %
The firm’s 50 day moving average is $1.23 and its 200 day moving average is $1.11.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Featured Articles
- Five stocks we like better than Nutriband
- 3 Best Fintech Stocks for a Portfolio Boost
- Texas Roadhouse Stock Steering for New Highs This Year
- How to Buy Cheap Stocks Step by Step
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Stock Market Upgrades: What Are They?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
